Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Elevance Health, Inc. publishes a filing, an earnings call transcript or a press release.

Get ELV alerts

About Gail Boudreaux

Gail Boudreaux is recorded as CEO at Elevance Health, Inc. (ELV). The proxy statement of Elevance Health, Inc. reports total compensation of $22,582,314 for Gail Boudreaux in fiscal 2025, including a base salary of $1,600,000. Disclosed compensation is on record for 9 fiscal years. Gail Boudreaux has spoken on 26 earnings calls across 1 company, most recently for Elevance Health, Inc. on October 21, 2026. Elevance Health, Inc. is classified in the Healthcare Plans industry within the Healthcare sector. Other leadership on record at Elevance Health, Inc. includes Mark B. Kaye (CFO), Ronald W. Penczek (Chief Accounting Officer), Amy W. Schulman (Board Member) and 3 others.

Gail Boudreaux on recent calls

“Elevance Health delivered strong third quarter results with Medicaid, Medicare Advantage, and individual ACA, each contributing to our better than expected performance.”
CEO, Elevance Health 2026 Q3 Earnings Call ·
“Elevance Health delivered second quarter results ahead of our outlook, reflecting favorable benefit expense performance, discipline to execution, and the actions we are taking to manage health care costs more effectively across the enterprise.”
CEO, Elevance Health, Inc. Q2 FY2026 Earnings Call ·
“So we're going to continue to scale what we're doing but bottom line I think it's important that our business we feel is performing well and those actions are going to continue to grain gain traction throughout the year and that reinforces our confidence so thanks very much for the question next question please next…”
CEO, Elevance Health, Inc. Q1 FY2026 Earnings Call ·
“Affordability remains the central challenge in healthcare. At Elevance Health, our focus is on improving outcomes, making care easier to access and navigate, and managing costs responsibly.”
CEO, Elevance Health, Inc. Q4 FY2025 Earnings Call ·
“The industry has been challenged by rising medical and pharmacy costs and regulatory changes that will impact coverage for millions of Americans. At Elevance Health, we're focused on lowering the total cost of care and improving the member experience.”
CEO, Elevance Health, Inc. Q3 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Elevance Health, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Elevance Health, Inc. (ELV) $1,600,000 $22,582,314
2024 Elevance Health, Inc. (ELV) $1,600,000 $20,471,976
2023 Elevance Health, Inc. (ELV) $1,600,000 $21,889,039
2022 Elevance Health, Inc. (ELV) $1,600,000 $20,931,081
2021 Elevance Health, Inc. (ELV) $1,561,538 $19,348,241
2020 Elevance Health, Inc. (ELV) $1,400,000 $17,109,952
2019 Elevance Health, Inc. (ELV) $1,400,000 $15,473,139
2018 Elevance Health, Inc. (ELV) $1,400,000 $14,184,276
2017 Elevance Health, Inc. (ELV) $161,538 $2,166,253

Recent activity

Show 14 earlier activities